Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Grubb & Ellis Healthcare REIT II, Inc, the healthcare arm of Grubb & Ellis Company ( ) , recently acquired a five-building portfolio of skilled nursing facilities from New Courtland Elder Services, Inc., an unaffiliated third party, for $75 million.
The portfolio is spread across different locations in Philadelphia and spans approximately 392,000 square feet and provides for 1200 patient beds.
The acquisition was funded through borrowings under the company’s line of credit. Since 2001, the portfolio has witnessed capital improvements of approximately $33 million
The entire portfolio of five buildings is currently leased to Mid-Atlantic Health Care, LLC. As per the terms of the lease, Mid-Atlantic is in charge of all operational and maintenance expenses of the portfolio. The existing lease expires in 2026 but carries three five-year renewals and one 59-month renewal options.
Skilled nursing facilities hold a significant portion of the Grubb & Ellis Healthcare portfolio owing to its huge demand. However, constrained supply is a growing concern for the company. This acquisition makes the company one of the largest owners of skilled nursing facilities in Philadelphia and puts it in an excellent position to tap the growing demand for skilled nursing facilities.
Grubb & Ellis Healthcare intends to qualify as a real estate investment trust (REIT) that seeks to protect its shareholders’ value. The company plans to raise approximately $3 billion in equity to acquire a diversified portfolio of real estate assets, focusing primarily on medical office buildings and other healthcare facilities.
Grubb & Ellis currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We are also maintaining our long-term Neutral recommendation on the stock.
One of its competitors, CB Richard Ellis Group, Inc ( CBG - Analyst Report ) currently retains a Zacks #3 Rank.
Read the full reports :
Analyst Report on CBG